These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5165569)

  • 1. Synthesis and pharmacological effects of some alkyl-, aryl-, and aralkylsydnonimines.
    Yashunskii VG; Gorkin VZ; Mashkovskii MD; Altshuler RA; Veryovkina IV; Kholodov LE
    J Med Chem; 1971 Oct; 14(10):1013-5. PubMed ID: 5165569
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synthesis, pharmacological properties and effect upon monoamine oxidase activity of some sydnoneimines].
    Iashunskiĭ VG; Mashkovskiĭ MD; Gorkin VZ; Kholodov LE; Al'tshuler RA; Polezhaeva AI; Verevkina IV
    Farmakol Toksikol; 1970; 33(3):297-302. PubMed ID: 5453024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 5. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles.
    Barthwal JP; Tandon SK; Agarwal VK; Dixit KS; Parmar SS
    J Pharm Sci; 1973 Apr; 62(4):613-7. PubMed ID: 4698982
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and pharmacological properties of symmetrical 2,5-disubstituted 1,3,4-oxadiazoles.
    Sharma BL; Tandon SK
    Pharmazie; 1984 Dec; 39(12):858-9. PubMed ID: 6099575
    [No Abstract]   [Full Text] [Related]  

  • 8. Substrate-selective inhibition of monoamine oxidase by some cyclopropylamino substituted oxadiazoles.
    Long RF; Mantle TJ; Wilson K
    Biochem Pharmacol; 1976 Feb; 25(3):247-52. PubMed ID: 1267821
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and preliminary pharmacological studies of some 3-substituted 5-amino-1,2,4-oxadiazoles.
    Cavalleri B; Volpe G; Del Turco BR; Diena A
    Farmaco Sci; 1976 Jun; 31(6):393-402. PubMed ID: 819298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
    Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I
    Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880
    [No Abstract]   [Full Text] [Related]  

  • 11. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine.
    Florvall L; Ask AL; Ogren SO; Ross SB
    J Med Chem; 1978 Jan; 21(1):56-63. PubMed ID: 22755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions at adrenergic nerve endings.
    Salerni OL
    J Indiana State Med Assoc; 1972 Jun; 65(6):498-9. PubMed ID: 4643468
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of and means of normalizing the deamination of nitrogenous compounds in the liver in experimental neoplasms].
    Khuzhamberdiev M; Romanova LA; Neĭfakh EA; Gorkin VZ
    Vopr Med Khim; 1973; 19(4):415-22. PubMed ID: 4802179
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.